01/16/2025
5:31 PM | Bressi Jerome Charles (Reporting)
Fate Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
5:32 PM | Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
5:36 PM | Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:05 PM | Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:06 PM | Bressi Jerome Charles (Reporting)
Fate Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
2:12 PM | Fate Therapeutics (Subject)
TAHL CINDY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
2:12 PM | Bressi Jerome Charles (Reporting)
Fate Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
2:20 PM | Fate Therapeutics (Subject)
Valamehr Bahram (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2024
8:00 PM | Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SCHEDULE 13D/A | |
12/26/2024
8:00 PM | Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
8:00 PM | Fate Therapeutics (Subject)
Redmile Group, LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for FATE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Fate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
12/16/2024
8:00 PM | Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
1:33 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:50 PM | Fate Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
10/25/2024
8:37 PM | Boxer Capital Management, LLC (Filed by)
Fate Therapeutics (Subject)
| Form SC 13G/A | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Fate Therapeutics (Subject)
| Form SC 13G/A | |
08/30/2024
3:21 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:01 PM | Fate Therapeutics (Issuer)
Xu Yuan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
9:34 AM | Fate Therapeutics (Subject)
Xu Yuan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
4:59 PM | Fate Therapeutics (Issuer)
Mozaffarian Neelufar (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/31/2024
5:00 PM | Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
5:01 PM | Fate Therapeutics (Issuer)
Mozaffarian Neelufar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
5:05 PM | Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:03 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
5:19 PM | Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
5:20 PM | Fate Therapeutics (Issuer)
Lee Michael Stewart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:35 PM | Fate Therapeutics (Issuer)
RASTETTER WILLIAM H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:30 PM | Fate Therapeutics (Issuer)
Jooss Karin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
4:05 PM | Fate Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/10/2024
3:31 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
4:26 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
4:24 PM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
8:01 AM | Fate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
11:15 PM | Fate Therapeutics (Filer)
| Form EFFECT | |
04/26/2024
3:16 PM | Fate Therapeutics (Filer)
| Form ARS | |
03/25/2024
8:30 PM | Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:15 PM | Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13D/A | |
03/20/2024
4:30 PM | Fate Therapeutics (Filer)
| Form 424B5 | |
03/04/2024
12:29 PM | Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free FATE Stock Alerts